Saturday 17 October 2026 Export CSCIF’s income statement to Excel — free account

COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.’s revenue for fiscal 2025 (year ended December 2025) was $7.5 million, down 21.8% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS grew 92.6% and free cash flow grew 113.3%, each against the same quarter a year earlier.

6.49 0.24 +3.84%

Follow CSCIF

Alert me

Market cap: $8.6M
P/E: 1.0×
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: −2.08
Beneish M: −2.95
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.26	0.36
P/S ratio Full definition →		0.30	0.29	0.13	0.27
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(3.87)	(1.48)	(0.49)	4.00
P/B ratio Full definition →		0.51	0.57	0.07	0.16
Price to Tangible BV Full definition →		0.80	1.07	0.07	0.16
EV/Sales Full definition →		(0.69)	(0.68)	(0.49)	(0.33)
EV/EBITDA Full definition →		0.50	0.55	0.53	0.58
EV/Operating CF Full definition →		0.59	0.61	0.45	0.77
EV/FCF Full definition →		0.56	0.60	0.48	0.93
Quick Ratio Full definition →		2.54	2.37	4.15	3.41
Current Ratio Full definition →		3.47	3.18	5.57	4.33
Net Debt/EBITDA Full definition →		4.19	2.22	12.87	(6.95)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.25	0.27	0.32	0.38
Operating CF/Net income Full definition →		0.37	0.67	(0.20)	(2.97)
Capex/Depreciation Full definition →		0.01	0.67	0.02	0.00
Interest Coverage Full definition →		(54.02)	(76.06)	(15.87)	8.27
Research and Development Expense of Revenue Full definition →		35.54%	67.57%	9.32%	4.20%
Selling, General and Administrative Expense of Revenue Full definition →		141.67%	145.86%	71.35%	37.64%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		(1.42%)	3.98%	0.05%	0.00%
Graham Net Nets Full definition →		(1.89)	(2.80)	5.50	2.37
Graham Number Full definition →		0.00	0.00	35.97	44.79
Earnings Yield Full definition →		(574.55%)	(476.26%)	385.32%	274.70%
Free Cash Flow Yield Full definition →		(402.83%)	(391.38%)	(766.41%)	(128.89%)
Revenue per Share Full definition →		1.40	2.10	1.80	3.00
Operating CF per Share Full definition →		(0.64)	(1.39)	(2.08)	0.57
Capex per Share Full definition →		0.00	0.18	0.01	0.00
Free Cash Flow per Share Full definition →		(0.63)	(1.21)	(2.07)	0.57
Cash per Share Full definition →		8.05	6.93	4.78	5.04
Shareholders Equity per Share Full definition →		4.80	3.64	14.63	14.17
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.80	3.64	14.63	14.17
Free Cash Flow Full definition →		(0.67)	(1.28)	(2.17)	0.60
Working Capital Full definition →		9.85	7.89	7.71	7.45
Capital Expenditures Full definition →		0.00	0.19	0.01	0.00
Net Current Asset Value Full definition →		(4.94)	(6.09)	5.87	5.69
EV/EBIT Full definition →		0.48	0.49	0.46	0.46
Capex to Sales Full definition →		0.00	(0.09)	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		1.81	1.87	1.93	2.58
Average Payables Full definition →		3.38	3.31	2.82	1.93
Average Inventory Full definition →		2.53	2.00	1.78	1.39
Average Assets Full definition →		33.81	28.25	24.99	23.20
Average Common Equity Full definition →		12.55	8.50	12.73	10.97

Show all line items

Columns are period end dates

Stockrow Weekly